2025 annual financial data

TScan Therapeutics 2025 Net margin

Direct answer

Net margin was -1,256.81%.

Operating income was -135.81M USD and net income was -129.77M USD.
Operating cash flow was -135.32M USD.

Get free TScan Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
10.33M USD
Operating income
-135.81M USD
Net income
-129.77M USD
Operating cash flow
-135.32M USD